657
Participants
Start Date
October 31, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Lapaquistat acetate
Lapaquistat acetate 50 mg, tablets, orally, once daily for up to 12 weeks.
Placebo
Lapaquistat acetate placebo-matching tablets, orally, once daily for up to 12 weeks.
Tallinn
Tartu
Balatonfüred
Budapest
Debrecen
Érd
Pécs
Szekszárd
Beersheba
Hadera
Haifa
Jerusalem
Kfar Saba
Nahariya
Safed
Tel Aviv
Daugavpils
Kuldīga
Riga
Amsterdam
Breda
GA Nijmegen
Groningen
Hoorn
Rotterdam
Utrecht
Zoetermeer
Ålesund
Elverum
Hamar
Kongsberg
Oslo
Moscow
Saint Petersburg
Saratov
Tyumen
Volgograd
Bratislava
Dolný Kubín
Košice
Nitra
Nové Mesto nad Váhom
Trebišov
Córdoba
Madrid
Pontevedra
REUS (Tarragona)
Valencia
Dnipro
Kharkiv
Kiev
Kyiv
Lutsk
Lviv
Belfast
Bolton
Glasgow, Scotland
Oldham
Paignton, Devon
Sheffield
Lead Sponsor
Takeda
INDUSTRY